Carlier, P. G., Azzabou, N., de Sousa, P. L., Hicks, A., Boisserie, J. M., Amadon, A., Carlier, R. Y., Wary, C., Orlikowski, D., Laforet, P. :
Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients
J Inherit Metab Dis, 2015 ; 38 (3) : 565-572
Publications (1184)
Pollanen, E., Kangas, R., Horttanainen, M., Niskala, P., Kaprio, J., Butler-Browne, G., Mouly, V., Sipila, S., Kovanen, V. :
Intramuscular sex steroid hormones are associated with skeletal muscle strength and power in women with different hormonal status Aging Cell, 2015 ; 14 (2) : 236-248
Intramuscular sex steroid hormones are associated with skeletal muscle strength and power in women with different hormonal status Aging Cell, 2015 ; 14 (2) : 236-248
Hervier, B., Benveniste, O. :
Le rituximab au cours des myopathies inflammatoires : << une revolution neolithique >> Rev Med Interne, 2015 ; 36 (8) : 505-8
Le rituximab au cours des myopathies inflammatoires : << une revolution neolithique >> Rev Med Interne, 2015 ; 36 (8) : 505-8
Trochet, D, Prudhon, B, Vassilopoulos, S, Bitoun, M :
Therapy for dominant inherited diseases by Allele-Specific RNA Interference: Successes and Pitfalls Curr Gene Ther, 2015 ; 15 (5) : 503-10
Therapy for dominant inherited diseases by Allele-Specific RNA Interference: Successes and Pitfalls Curr Gene Ther, 2015 ; 15 (5) : 503-10
Goyenvalle, A., Griffith, G., Babbs, A., Andaloussi, S. E., Ezzat, K., Avril, A., Dugovic, B., Chaussenot, R., Ferry, A., Voit, T., Amthor, H., Buhr, C., Schurch, S., Wood, M. J., Davies, K. E., Vaillend, C., Leumann, C., Garcia, L. :
Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers Nat Med, 2015 ; 21 (3) : 270-275
Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers Nat Med, 2015 ; 21 (3) : 270-275
Tsonis, A I, Zisimopoulou, P, Lazaridis, K, Tzartos, J, Matsigkou, E, Zouvelou, V, Mantegazza, R, Antozzi, C, Andreetta, F, Evoli, A, Deymeer, F, Saruhan-Direskeneli, G, Durmus, H, Brenner, T, Vaknin, A, Berrih-Aknin, S, Behin, A, Sharshar, T, De Baets, M, Losen, M, Martinez-Martinez, P, Kleopa, K A, Zamba-Papanicolaou, E, Kyriakides, T, Kostera-Pruszczyk, A, Szczudlik, P, Szyluk, B, Lavrnic, D, Basta, I, Peric, S, Tallaksen, C, Maniaol, A, Casasnovas Pons, A, Pitha, J, Jakubíkova, M, Hanisch, F, Tzartos, S J :
MuSK autoantibodies in myasthenia gravis detected by cell based assay – a multinational study J Neuroimmunol, 2015 ; 284 : 10-17
MuSK autoantibodies in myasthenia gravis detected by cell based assay – a multinational study J Neuroimmunol, 2015 ; 284 : 10-17
Avidan, N., Le Panse, R., Harbo, H. F., Bernasconi, P., Poulas, K., Ginzburg, E., Cavalcante, P., Colleoni, L., Baggi, F., Antozzi, C., Truffault, F., Horn-Saban, S., Poschel, S., Zagoriti, Z., Maniaol, A., Lie, B. A., Bernard, I., Saoudi, A., Illes, Z., Casasnovas Pons, C., Melms, A., Tzartos, S., Willcox, N., Kostera-Pruszczyk, A., Tallaksen, C., Mantegazza, R., Berrih-Aknin, S., Miller, A. :
VAV1 and BAFF, via NFkappaB pathway, are genetic risk factors for myasthenia gravis Ann Clin Transl Neurol, 2014 ; 1 (5) : 329-39
VAV1 and BAFF, via NFkappaB pathway, are genetic risk factors for myasthenia gravis Ann Clin Transl Neurol, 2014 ; 1 (5) : 329-39
Couvrat-Desvergnes, G., Masseau, A., Benveniste, O., Bruel, A., Hervier, B., Mussini, J. M., Buob, D., Hachulla, E., Remy, P., Azar, R., Namara, E. M., MacGregor, B., Daniel, L., Lacraz, A., De Broucker, T., Rouvier, P., Carli, P., Laville, M., Dantan, E., Hamidou, M., Moreau, A., Fakhouri, F. :
The spectrum of renal involvement in patients with inflammatory myopathies Medicine (Baltimore), 2014 ; 93 (1) : 33-41
The spectrum of renal involvement in patients with inflammatory myopathies Medicine (Baltimore), 2014 ; 93 (1) : 33-41
Hogrel, J. Y., Allenbach, Y., Canal, A., Leroux, G., Ollivier, G., Mariampillai, K., Servais, L., Herson, S., Decostre, V., Benveniste, O. :
Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials Neuromuscul Disord, 2014 ; 24 (7) : 604-610
Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials Neuromuscul Disord, 2014 ; 24 (7) : 604-610
Quijano-Roy, S., Rivier, F, Romero, N. B. :
Myopathies congénitales Lettre du Neurologue, 2014 ; 18 (7) : 263-266
Myopathies congénitales Lettre du Neurologue, 2014 ; 18 (7) : 263-266
